Plimoth Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.82M | Sell |
65,039
-1,375
| -2% | -$159K | 1.75% | 11 |
|
|
2025
Q4 | $6.99M | Buy |
66,414
+1,384
| +2% | +$130K | 1.56% | 12 |
|
|
2025
Q3 | $5.46M | Buy |
65,030
+4,691
| +8% | +$386K | 1.24% | 20 |
|
|
2025
Q2 | $4.78M | Buy |
60,339
+5,658
| +10% | +$450K | 1.15% | 23 |
|
|
2025
Q1 | $4.91M | Buy |
54,681
+6,535
| +14% | +$610K | 1.28% | 20 |
|
|
2024
Q4 | $4.79M | Buy |
48,146
+511
| +1% | +$52.7K | 1.23% | 21 |
|
|
2024
Q3 | $5.41M | Buy |
47,635
+1,954
| +4% | +$232K | 1.36% | 20 |
|
|
2024
Q2 | $5.66M | Sell |
45,681
-784
| -2% | -$101K | 1.51% | 16 |
|
|
2024
Q1 | $6.13M | Sell |
46,465
-978
| -2% | -$121K | 1.63% | 12 |
|
|
2023
Q4 | $5.17M | Buy |
47,443
+1,060
| +2% | +$110K | 1.49% | 17 |
|
|
2023
Q3 | $4.78M | Buy |
46,383
+277
| +0.6% | +$29.9K | 1.5% | 16 |
|
|
2023
Q2 | $5.32M | Sell |
46,106
-643
| -1% | -$73K | 1.59% | 15 |
|
|
2023
Q1 | $4.97M | Buy |
46,749
+1,107
| +2% | +$120K | 1.54% | 16 |
|
|
2022
Q4 | $5.06M | Sell |
45,642
-111
| -0.2% | -$11.3K | 1.63% | 12 |
|
|
2022
Q3 | $3.94M | Sell |
45,753
-124
| -0.3% | -$11.1K | 1.36% | 19 |
|
|
2022
Q2 | $4.18M | Buy |
45,877
+16,098
| +54% | +$1.43M | 1.32% | 18 |
|
|
2022
Q1 | $2.44M | Sell |
29,779
-156
| -0.5% | -$12.3K | 0.65% | 55 |
|
|
2021
Q4 | $2.29M | Buy |
29,935
+589
| +2% | +$46.9K | 0.58% | 57 |
|
|
2021
Q3 | $2.2M | Buy |
29,346
+294
| +1% | +$22.4K | 0.62% | 55 |
|
|
2021
Q2 | $2.26M | Sell |
29,052
-3,667
| -11% | -$273K | 0.63% | 54 |
|
|
2021
Q1 | $2.41M | Buy |
32,719
+480
| +1% | +$35.4K | 0.71% | 50 |
|
|
2020
Q4 | $2.52M | Sell |
32,239
-6,984
| -18% | -$534K | 0.79% | 46 |
|
|
2020
Q3 | $3.1M | Sell |
39,223
-1,125
| -3% | -$88.1K | 1.04% | 31 |
|
|
2020
Q2 | $2.98M | Buy |
40,348
+522
| +1% | +$39.3K | 1.06% | 28 |
|
|
2020
Q1 | $2.92M | Sell |
39,826
-303
| -0.8% | -$23.8K | 1.23% | 18 |
|
|
2019
Q4 | $3.48M | Sell |
40,129
-388
| -1% | -$31.9K | 1.13% | 20 |
|
|
2019
Q3 | $3.25M | Sell |
40,517
-1,100
| -3% | -$88.2K | 1.07% | 22 |
|
|
2019
Q2 | $3.33M | Sell |
41,617
-980
| -2% | -$75K | 1.1% | 21 |
|
|
2019
Q1 | $3.38M | Sell |
42,597
-968
| -2% | -$72.4K | 1.12% | 23 |
|
|
2018
Q4 | $3.18M | Sell |
43,565
-1,232
| -3% | -$87K | 1.17% | 21 |
|
|
2018
Q3 | $3.03M | Sell |
44,797
-1,163
| -3% | -$74.1K | 0.98% | 26 |
|
|
2018
Q2 | $2.66M | Sell |
45,960
-1,771
| -4% | -$99.9K | 0.91% | 29 |
|
|
2018
Q1 | $2.48M | Sell |
47,731
-210
| -0.4% | -$11.3K | 0.86% | 34 |
|
|
2017
Q4 | $2.57M | Buy |
+47,941
| New | +$2.66M | 0.92% | 31 |
|
Other funds holding MRK
VCM
VPM
Plimoth Trust's MRK Position: Q1 2026 in Review
Plimoth Trust reduced its Merck (MRK) stake by 2.1% in Q1 2026, selling an estimated $159K and leaving 65,039 shares worth $7.82M. The position accounts for 1.75% of the portfolio, ranked #11.
Plimoth Trust first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Plimoth Trust held 65,039 shares of Merck worth $7.82M as of Q1 2026.
- Plimoth Trust sold 1,375 Merck shares in Q1 2026, an estimated $159K.
- Merck made up 1.75% of Plimoth Trust's portfolio in Q1 2026, its #11 holding.
- Plimoth Trust first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.